HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $695 | -65.5% | 8,160 | -68.2% | 0.09% | -56.4% |
| Q4 2022 | $2,017 | -99.4% | 25,640 | +426.5% | 0.20% | +461.1% |
| Q3 2022 | $361,000 | -49.4% | 4,870 | -55.5% | 0.04% | -55.6% |
| Q2 2022 | $714,000 | +20.6% | 10,950 | -2.0% | 0.08% | +22.7% |
| Q4 2021 | $592,000 | -53.9% | 11,170 | -3.5% | 0.07% | -54.5% |
| Q1 2021 | $1,284,000 | +79.3% | 11,570 | +61.1% | 0.14% | +3.6% |
| Q1 2020 | $716,000 | -68.6% | 7,180 | -63.8% | 0.14% | -61.6% |
| Q4 2019 | $2,277,000 | +163.5% | 19,817 | +189.4% | 0.36% | +140.1% |
| Q3 2019 | $864,000 | -31.9% | 6,847 | -51.6% | 0.15% | -20.4% |
| Q2 2018 | $1,268,000 | +205.5% | 14,145 | +149.8% | 0.19% | +208.1% |
| Q1 2018 | $415,000 | +18.6% | 5,662 | -6.2% | 0.06% | 0.0% |
| Q4 2017 | $350,000 | +61.3% | 6,039 | -19.5% | 0.06% | +5.1% |
| Q2 2016 | $217,000 | -39.6% | 7,500 | -13.4% | 0.06% | -52.8% |
| Q2 2015 | $359,000 | +71.8% | 8,658 | +65.3% | 0.12% | -65.1% |
| Q3 2013 | $209,000 | – | 5,239 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |